SCHEMBL22065294

SCHEMBL22065294

Cc1ccc(C(=O)Nc2cccc(Cl)c2)cc1NI

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KCNK3 O14649 3/20 0.58
KCNK9 Q9NPC2 2/20 0.58
NPC1 O15118 3/20 0.57
RAB9A P51151 3/20 0.57
ADORA3 P0DMS8 1/20 0.55
ADORA2A P29274 1/20 0.55
ADORA2B P29275 1/20 0.55
ADORA1 P30542 1/20 0.55
CNR2 P34972 1/20 0.55
BRAF P15056 3/20 0.54
SMN1; SMN2 Q16637 2/20 0.53
P4HTM Q9NXG6 1/20 0.53
MAOB P27338 1/20 0.53
LMNA P02545 1/20 0.52
PTBP1 P26599 1/20 0.52
KDM4E B2RXH2 1/20 0.51
MEN1 O00255 1/20 0.51
ALDH1A1 P00352 1/20 0.51
CYP1A2 P05177 1/20 0.51
MAPT P10636 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22065285 0.88 BRAF (0.60) KCNK3KCNK9NPC1RAB9AADORA3
SCHEMBL22065290 0.85 MEN1 (0.61) KCNK3KCNK9NPC1RAB9ABRAF
SCHEMBL22066357 0.85 HDAC8 (0.58) KCNK3KCNK9NPC1RAB9ACNR2
SCHEMBL22025353 0.85 KCNK3 (0.55) KCNK3KCNK9NPC1RAB9AADORA3
SCHEMBL22024688 0.85 CNR2 (0.55) KCNK3KCNK9NPC1RAB9AADORA3
SCHEMBL22065293 0.84 MAOB (0.53) KCNK3KCNK9NPC1RAB9ASMN1; SMN2
SCHEMBL22065403 0.84 ALDH1A1 (0.56) KCNK3KCNK9SMN1; SMN2KDM4EMEN1
SCHEMBL22065295 0.84 KCNK3 (0.58) KCNK3KCNK9NPC1RAB9ABRAF
SCHEMBL22065405 0.82 RXFP1 (0.67) KCNK3KCNK9NPC1RAB9ASMN1; SMN2
SCHEMBL23092213 0.81 NPC1 (0.62) KCNK3KCNK9NPC1RAB9AADORA3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3663293-A1 SUBSTITUTED PENTA- AND HEXA-HETEROCYCLIC COMPOUNDS, PREPARATION METHOD THEREFOR, DRUG COMBINATION AND USE THEREOF Xiamen University (CN) 2020-06-10 EP disclosed